Literature DB >> 14582141

Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression.

Francesco Benedetti1, Alessandro Serretti, Cristina Colombo, Barbara Barbini, Cristina Lorenzi, Euridice Campori, Enrico Smeraldi.   

Abstract

Recent studies showed that a polymorphism (T to C nucleotide substitution) in the 3' flanking region of the human CLOCK gene is associated with diurnal preferences of human healthy subjects, with higher "eveningness" in subjects carrying at least one copy of the C allele. We investigated the possible role of CLOCK gene polymorphism in the regulation of diurnal mood fluctuations during a major depressive episode. Sample (n = 101) was collected, in the context of previously reported trials, among patients affected by bipolar disorder type I, depressive episode without psychotic features, free of psychotropic medications. Perceived mood levels were assessed three times a day with self-administered visual analogue scales. Genotype groups showed no significant difference in diurnal mood fluctuations. When stratifying the sample by including only patients with an adequate period of observation (duration of illness higher than 5 years, n = 69), we post-hoc observed a significantly higher recurrence rate in homozygotes for the C variant, which was almost double than that of the other genotype groups. This preliminary observation leads to hypothesize a role for the CLOCK gene polymorphism in the regulation of long-term illness recurrence in bipolar disorder. Given the post-hoc nature of the finding, replication in independent samples is necessary to confirm it. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14582141     DOI: 10.1002/ajmg.b.20038

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  91 in total

1.  Searching for genetic clues at the interface of sleep and mood.

Authors:  Namni Goel
Journal:  Sleep       Date:  2012-06-01       Impact factor: 5.849

Review 2.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

Review 3.  Circadian rhythms and mood regulation: insights from pre-clinical models.

Authors:  Colleen A McClung
Journal:  Eur Neuropsychopharmacol       Date:  2011-08-11       Impact factor: 4.600

Review 4.  Animal models of bipolar mania: The past, present and future.

Authors:  R W Logan; C A McClung
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

5.  What can a clock mutation in mice tell us about bipolar disorder?

Authors:  Joseph T Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-02       Impact factor: 11.205

Review 6.  Clock gene variants in mood and anxiety disorders.

Authors:  Timo Partonen
Journal:  J Neural Transm (Vienna)       Date:  2012-04-27       Impact factor: 3.575

7.  Investigation of the T3111C CLOCK gene polymorphism in cluster headache.

Authors:  Sabina Cevoli; Mirella Mochi; Giulia Pierangeli; Stefano Zanigni; Daniela Grimaldi; Giuseppe Bonavina; Paola Torelli; Gian Camillo Manzoni; Pietro Cortelli; Pasquale Montagna
Journal:  J Neurol       Date:  2008-02-20       Impact factor: 4.849

Review 8.  Circadian genes, rhythms and the biology of mood disorders.

Authors:  Colleen A McClung
Journal:  Pharmacol Ther       Date:  2007-02-28       Impact factor: 12.310

9.  MicroRNAs suggest a new mechanism for altered brain gene expression in schizophrenia.

Authors:  Joseph T Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-26       Impact factor: 11.205

10.  Genome-wide association scan for five major dimensions of personality.

Authors:  A Terracciano; S Sanna; M Uda; B Deiana; G Usala; F Busonero; A Maschio; M Scally; N Patriciu; W-M Chen; M A Distel; E P Slagboom; D I Boomsma; S Villafuerte; E Sliwerska; M Burmeister; N Amin; A C J W Janssens; C M van Duijn; D Schlessinger; G R Abecasis; P T Costa
Journal:  Mol Psychiatry       Date:  2008-10-28       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.